Walgreen Co.

DUBAI, UAE, Oct. 31, 2024 /PRNewswire/ -- Amid rising costs in the U.S., the XRP Healthcare Prescription Savings Card is providing Americans with much-needed relief on medication expenses. Accepted at over 68,000 pharmacies, including major chains like Walmart, Walgreens, and CVS, the card offers savings of up to 80% on prescriptions and over-the-counter medications, free to download on the XRPH app with no hidden fees or subscription costs. Continue Reading Amid Rising Costs, XRP Healthcare Prescription Savings Card Making a Difference at 68,000 Pharmacies Across America: A Game-Changer for Individuals and Organizations Alike While not a complete solution for financial pressures, the card delivers meaningful savings on repeat medications, especially for those managing chronic conditions like diabetes, high blood pressure, and mental health. "With financial pressures mounting, our Prescription Savings Card offers a simple, no-cost solution to help families reduce their prescription expenses," says Kain Roomes, CEO of XRP Healthcare. Supported by AI-driven guidance through the XRPH app, users can access reliable healthcare information and personalized insights. This digital platform ensures access to trusted advice on managing health concerns affordably, bridging a critical gap in healthcare. Since launching in 2022, XRP Healthcare has successfully delivered on each phase of its growth roadmap, making significant strides in enhancing healthcare access. Entering the final quarter of 2024 with strong momentum, XRP Healthcare is set to close the year with impactful mergers and acquisitions in underserved markets like Uganda, furthering its mission to improve healthcare access in emerging regions. This growth positions the company as a leader in delivering cost-effective healthcare solutions to both established and developing markets. "Expanding into Uganda represents a pivotal step toward our vision of a truly global healthcare ecosystem," adds COO Laban Roomes, with a focus on strengthening affordable healthcare options in underserved markets. About XRP Healthcare XRP Healthcare is the first pharma and healthcare platform built on the XRP Ledger, leveraging blockchain and AI to transform access to affordable healthcare globally. Headquartered in Dubai, UAE, and Uganda, XRP Healthcare offers solutions like the Prescription Savings Card and an AI-powered chatbot, aimed at making healthcare accessible worldwide. The company's token, XRPH, is paired with USDT and listed on multiple reputable CEX exchanges, driving innovation in the digital and healthcare sectors. Photo - Logo - SOURCE XRP Healthcare WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global pharma e-commerce market in Europe size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.27% during the forecast period. Availability of internet provides convenience to consumers is driving market growth, with a trend towards growing acceptance in newly regulated european states. However, illegal and counterfeit trading of drugs through e-pharmacy poses a challenge. Key market players include Ace Chemist Direct, apo rot GmbH, Apotea AB, Arzneiprivat, Atropa Pharmacy, Chemist4U Innox Trading Ltd., Dirk Rossmann GmbH, DocMorris AG, EURO PHARM International Canada Inc., Farmacia Campoamor, Juvalis, McKesson Corp., myCARE e.k, Parafarmacia online, Pharmacy2U Ltd., Redcare Pharmacy, The French Pharmacy, UK MEDS Direct Ltd., Walgreens Boots Alliance Inc., and Wort and Bild Verlag Konradshohe GmbH and Co. KG. Continue Reading Technavio has announced its latest market research report titled pharma e-commerce market in Europe 2024-2028 Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report Market Driver Pharma e-commerce in Europe is witnessing significant growth due to the increasing demand for personalized medicine and health solutions. Leveraging data analytics and artificial intelligence, these platforms provide customized recommendations, treatment plans, and wellness programs based on individual preferences and health histories. Personalized medicine, which involves customizing medical treatment to each patient's unique characteristics, is facilitated through a wide range of offerings, including specialty drugs and compounded medications. Patients can work with healthcare professionals to develop personalized treatment regimens and order necessary medications online. The trend extends beyond disease treatment to encompass wellness and preventive care, with e-commerce platforms offering health supplements, vitamins, and wellness products tailored to individual health goals. The European pharma e-commerce market is expected to grow, fueled by this trend and the innovation it inspires, including genetic testing services and health monitoring devices. The European pharma e-commerce market is experiencing significant growth, with medications, medical supplies, and healthcare products leading the way. Remote healthcare services, such as telemedicine and e-prescriptions, are also trending, especially among the elderly population with chronic diseases. Consumer convenience and cost-effective solutions are key drivers, with many opting for online pharmacies and mail-order services. However, challenges persist, including counterfeit pharmaceuticals, data protection, and consumer trust. Healthcare systems and internet connectivity are essential for the success of digital healthcare solutions. Omnichannel retailing, including inventory data and logistics, is crucial for supply chain efficiency. Direct sales to healthcare professionals are also increasing. E-prescriptions and digital prescription services are becoming more common, but illegal and unregulated online pharmacies pose a threat to consumer safety. Quality assurance and regulatory compliance are essential to maintain consumer trust. Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution! Market Challenges The proliferation of counterfeit drugs in the European pharma e-commerce market poses a significant challenge. These drugs, sold through virtual platforms, undermine industry integrity and pose health risks due to incorrect ingredients or dosages. Illicit drugs such as cannabis, heroin, and cocaine are commonly traded. This globalized counterfeit drug trade increases societal threats, including drug-related crimes and fatalities from overdoses. E-commerce's lack of regulation and oversight enables third-party sellers to exploit loopholes, making it difficult for authorities to monitor and control sales effectively. This situation negatively impacts the growth of the pharma e-commerce market in Europe, potentially hindering its forecasted expansion. The European pharma e-commerce market is experiencing significant growth due to an aging population and the rise of online and mail-order pharmacies. Challenges include managing chronic diseases, ensuring patient safety, and addressing illegal and unregulated online pharmacies. Digital prescription services and e-prescriptions are key trends, but logistics and inventory data management are crucial for success. Omnichannel retailing, including OTC medications and prescription medications, targets a large patient population. Health insurers and digital healthcare platforms are driving demand for electronic prescriptions and mobile applications. AI chatbots and machine learning enable personalized patient care, while data analytics and prescription refills enhance convenience. Cross-border e-commerce and drug counterfeiting pose risks, requiring strict regulation and biometric identification for security. The diabetes segment and immune-system diseases are major growth areas in the B2C market. Manufacturer-owned marketplaces and digital technologies are transforming the industry, offering new opportunities for growth. Discover how AI is revolutionizing market trends- Get your access now! Segment Overview This pharma e-commerce market in Europe report extensively covers market segmentation by Product 1.1 Medications 1.2 Health/wellness and nutrition 1.3 Personal care and essentials Type 2.1 Rx 2.2 OTC Geography 3.1 Europe 1.1 Medications- The European pharma e-commerce market is experiencing significant growth due to the increasing demand for medications as the population ages and the prevalence of chronic diseases rises. Online pharmacies offer consumers the convenience of purchasing essential medications without visiting physical pharmacies, making it an attractive option for individuals with mobility issues, busy lifestyles, or those living in remote areas. These platforms provide access to a wide range of medications, including specialty drugs and rare medications, ensuring consumers have access to the necessary treatments regardless of their location. Additionally, online platforms offer valuable information on medication side effects, low-cost substitutes, and potential drug interactions, enabling consumers to make informed purchasing decisions. These factors contribute to the anticipated growth of the medications segment and the pharma e-commerce market in Europe during the forecast period. Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics Research Analysis Pharma e-commerce in Europe is experiencing significant growth, driven by the increasing elderly population and the demand for convenient healthcare solutions. Online pharmacies and mail-order pharmacies are becoming popular, offering prescription medications, over-the-counter pharmaceuticals, and healthcare products. Telemedicine and digital prescription services enable remote healthcare consultations and electronic prescriptions. However, the rise of illegal online pharmacies poses a threat, selling counterfeit pharmaceuticals and compromising data protection. Two-factor authentication and data analytics help ensure security and personalized services. Mobile applications facilitate prescription refills and remote healthcare services. Artificial intelligence and data analytics improve patient care and optimize supply chain management. Overall, pharma e-commerce in Europe offers a wide range of digital platforms for medications, medical supplies, and healthcare products, enhancing consumer convenience and accessibility for chronic disease management and life expectancy improvement. Market Research Overview The Pharma E-Commerce Market in Europe is experiencing significant growth due to the increasing elderly population, chronic diseases, and advancements in digital healthcare. Online pharmacies and mail-order pharmacies are becoming increasingly popular, offering convenience and accessibility to patients. Telemedicine and e-prescriptions are also on the rise, enabling remote healthcare services and digital prescription services. However, the market also faces challenges such as illegal and unregulated online pharmacies, drug counterfeiting, and healthcare accessibility issues. Healthcare professionals, health insurers, and manufacturer-owned marketplaces are also playing key roles in this evolving landscape. Omnichannel retailing, inventory data management, logistics, and cost-effective solutions are essential for success in this market. Digital technologies, including AI chatbots, machine learning, and data analytics, are transforming the industry, offering personalized healthcare and consumer convenience. E-commerce platforms, mobile applications, prescription refills, and two-factor authentication are also driving growth in the B2C segment. Data protection and quality assurance are crucial for consumer trust, while cross-border e-commerce and medical tourism are expanding opportunities for growth. The market for prescription medications, OTC medications, medical supplies, and healthcare products is expected to continue growing, fueled by increasing healthcare expenses, internet penetration, and the need for cost-effective solutions. Table of Contents: 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation Product Medications Health/wellness And Nutrition Personal Care And Essentials Type Rx OTC Geography Europe 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

BOSTON--( BUSINESS WIRE )-- Susan G. Komen ®, the world’s leading breast cancer organization, today announced it will host three MORE THAN PINK Walks in New England this fall. The Komen MORE THAN PINK Walks – taking place in Manchester, VT, Cambridge, MA, and Hartford, CT – will bring together thousands of survivors, supporters and advocates to raise critical funds to advance Komen’s mission and provide support for people facing this disease now. The upcoming MORE THAN PINK Walks in New England will take place: Manchester, Vermont, Saturday, Oct. 5, 2024 at Northshire Civic Center – Hunter Park Register at: komen.org/vermontwalk Cambridge, Massachusetts, Saturday, Oct. 26, 2024 at North Point Park Register at: www.komen.org/massachusettswalk Hartford, Connecticut, Sunday, Oct. 27, 2024 at Bushnell Park Register at: www.komen.org/connecticutwalk Funds raised at the MORE THAN PINK Walks will allow Komen to meet the immediate needs of breast cancer patients through its free Breast Care Helpline and offer services such as patient navigation, financial assistance and emotional support. The walks will also fund research breakthroughs that allow more lives to be saved from breast cancer and bring cures for all breast cancers closer. Every 12 minutes, a woman in the U.S. dies from breast cancer. In 2024 alone, an estimated 670 women in Vermont will be diagnosed with breast cancer and 80 will lose their lives to the disease, 7,150 women in Massachusetts will be diagnosed with breast cancer and 730 will lose their lives to the disease, and 3,790 women in Connecticut will be diagnosed with breast cancer and 420 will lose their lives to the disease. Experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments. In Fiscal Year 2024, the Komen Financial Assistance program provided $346,000 to 593 people in Vermont, Massachusetts and Connecticut who were in breast cancer treatment or living with metastatic breast cancer. Komen’s Patient Care Center additionally helped 792 people in the three states who were experiencing barriers to the breast health care or support they needed. "We are thrilled to be hosting three MORE THAN PINK Walks in New England this fall, where together we can make a profound impact in the fight against breast cancer," said Nicole Marohn, Executive Director at Susan G. Komen. "Supporting individuals in our communities who are facing breast cancer is essential to our mission, but we cannot do it alone. These Walks are not just events; they are pivotal moments to secure vital funds that will make equitable care available to all as we take a powerful stand against this devastating disease." Bank of America is the national presenting sponsor and Walgreens, Novartis and Lily are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events. To learn more, visit komen.org . About Susan G. Komen ® Susan G. Komen ® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/ .